| Filed | Description | |
|---|---|---|
| 3/2/26 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 8/11/25 | 1.01 Material Agreement | → |
| 6/27/25 | 1.01 Material Agreement | → |
| 8/2/24 | 1.01 Material Agreement | → |
| 12/26/23 | 1.01 Material Agreement | → |
| 11/2/23 | 1.02 Agreement Terminated | → |
| ↓ 8 more | ||
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.